Skip to content
Skip to product information
1 of 1

LONGLIFE ZINC 25 MG 100 TABLETS

LONGLIFE ZINC 25 MG 100 TABLETS

Regular price €14,12 EUR
Sale price €14,12 EUR Regular price €15,20 EUR
Sale Sold out
Tax included.

SKU

933784783

Low stock

Vendor

LONGLIFE Srl

Delivery time: 48/72 hours

Free Shipping: Orders over €70

This product page, including its Product Information Leaflet, has been automatically translated.
  • American Express
  • Apple Pay
  • Google Pay
  • Klarna
  • Maestro
  • Mastercard
  • PayPal
  • Shop Pay
  • Union Pay
  • Visa
View full details

LongLife
Zinc 25 mg

Description
Highly bioavailable zinc food supplement, useful for:
-protecting cells from oxidative stress;
-maintaining bones, hair, nails, and skin;
-maintaining blood testosterone levels;
-the cell division process;
-macronutrient metabolism;
-carbohydrate metabolism;
-normal DNA synthesis;
-fatty acid metabolism;
-acid-base metabolism;
-vitamin A metabolism;
-fertility and reproduction;
-the immune system;
-cognitive function;
-protein synthesis;
-vision.
Suitable for vegetarians and vegans.

Ingredients
Bulking agents: dibasic calcium phosphate, microcrystalline cellulose; zinc citrate; thickener: sodium carboxymethylcellulose; anti-caking agents: stearic acid, vegetable magnesium stearate; coating agents: hydroxypropyl methylcellulose, polyethylene glycol.

Gluten-free.

Nutritional characteristics
Average values Per ½ tablet
Zinc 12.5 mg (125% NRV*)
*NRV: Nutrient Reference Values.

Directions for use
Take half (½) tablet daily with water during a meal.

Warnings
Food supplements should not be considered a substitute for a varied diet and should be used as part of a healthy and balanced lifestyle. Do not exceed the recommended daily dose. Keep out of reach of children under three years of age.

Storage
Store in a cool, dry place.
Shelf life unopened: 48 months.

Format
Jar of 100 tablets of 0.450 g.
Net weight: 45 g.

Code 0384

Bibliography
-Zinc, infections and immunosenescence. Mech Ageing Dev 2000 Dec 20; 121 (1-3):21-35.
-Hyman L, Neborsky R. Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 2002 Jun;13 (3):171-5.
About your query!
To top